A US panel has recommended easing restrictions on the sale and use of increasingly popular peptides, despite acknowledging existing safety concerns. These peptides, often marketed for weight loss, anti-aging, and muscle gain, have seen a surge in demand but lack comprehensive regulation. The panel believes increased access could foster research and innovation, outweighing the potential downsides if appropriate safeguards are implemented. However, experts caution that the long-term effects of these compounds remain largely unknown, and the potential for adverse reactions exists. The recommendation doesn’t eliminate oversight, but suggests a shift toward more flexible regulations. The panel emphasized the need for ongoing monitoring and further study to assess the risks and benefits as peptide use becomes more widespread.